glp 1 drugs in development Emerging Trends the of GLP-1 Receptor Agonists The Multi-Sector Impacts of GLP-1RA

From a healthcare delivery perspective, the entry of GLIPIQ strengthens the domestic presence of advanced diabetes therapies without altering treatment protocols, which remain guided by clinical evaluation

Athletes may therefore have difficulty accessing GLP-1RAs or be reluctant to speak on their experience using it, creating a lack of research in this area

While their choices may help to inform the decision-making of plan sponsors in other industries, ultimately all employers will need to weigh the clinical and financial issues to ensure their benefit design reflects their philosophy, program objectives and fiscal reality.

PMID: 21159785

Diabetes Obes Metab 25(1):1835

FengWGaoCBiYWuMLiPShenSet al